Experienced in Peritonitis

Dr. Sunil Gandhi

Radiology
Bay Imaging Consultants Medical Group Inc.
2125 Oak Grove Rd Ste 200, 
Walnut Creek, CA 
Experienced in Peritonitis
Bay Imaging Consultants Medical Group Inc.
2125 Oak Grove Rd Ste 200, 
Walnut Creek, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sunil Gandhi is a Radiologist in Walnut Creek, California. Dr. Gandhi is rated as an Experienced provider by MediFind in the treatment of Peritonitis. His top areas of expertise are Osteopenia, Melorheostosis with Osteopoikilosis, Melorheostosis, and Chronic Cough.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiology
Licenses
Diagnostic Radiology in CA
Hospital Affiliations
John Muir Medical Center - Walnut Creek Campus
John Muir Medical Center - Concord Campus
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Bay Imaging Consultants Medical Group Inc.
2125 Oak Grove Rd Ste 200, Walnut Creek, CA 94598
Call: 925-296-7150
Other Locations
Bay Imaging Consultants Medical Group Inc.
140 Brookwood Rd Ste 100, Orinda, CA 94563
Call: 925-254-9090

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer With Either Phosphoinositide-3-kinase Catalytic Subunit Alpha (PIK3CA) Mutation or Phosphatase and Tensin Homolog Protein (PTEN) Loss Without PIK3CA Mutation
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer With Either Phosphoinositide-3-kinase Catalytic Subunit Alpha (PIK3CA) Mutation or Phosphatase and Tensin Homolog Protein (PTEN) Loss Without PIK3CA Mutation
Enrollment Status: Active_not_recruiting
Publish Date: November 05, 2025
Intervention Type: Drug
Study Drugs: alpelisib, nab-paclitaxel
Study Phase: Phase 3
EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy
EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Drug
Study Drugs: Imlunestrant, Exemestane, Fulvestrant, Abemaciclib
Study Phase: Phase 3
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 31, 2024
Intervention Type: Drug, Device
Study Drugs: Gemcitabine, Nab-paclitaxel
Study Phase: Phase 3
A Phase 2 Study of Avutometinib (VS-6766) (Dual RAF/MEK Inhibitor) as a Single Agent and In Combination With Defactinib (FAK Inhibitor) in Recurrent KRAS-Mutant (KRAS-MT) and BRAF-Mutant (BRAF-MT) Non-Small Cell Lung Cancer (NSCLC) (RAMP 202)
A Phase 2 Study of Avutometinib (VS-6766) (Dual RAF/MEK Inhibitor) as a Single Agent and In Combination With Defactinib (FAK Inhibitor) in Recurrent KRAS-Mutant (KRAS-MT) and BRAF-Mutant (BRAF-MT) Non-Small Cell Lung Cancer (NSCLC) (RAMP 202)
Enrollment Status: Completed
Publish Date: January 12, 2024
Intervention Type: Drug
Study Drugs: VS-6766, VS-6766+Defactinib
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
Enrollment Status: Completed
Publish Date: March 20, 2023
Intervention Type: Drug
Study Drugs: CB-839, Cabozantinib
Study Phase: Phase 2
A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Nab-Paclitaxel and Gemcitabine With or Without Olaratumab in the Treatment of First-Line Metastatic Pancreatic Cancer
A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Nab-Paclitaxel and Gemcitabine With or Without Olaratumab in the Treatment of First-Line Metastatic Pancreatic Cancer
Enrollment Status: Completed
Publish Date: June 28, 2022
Intervention Type: Drug
Study Drugs: Olaratumab, Nab-paclitaxel, Gemcitabine
Study Phase: Phase 1/Phase 2
View 5 Less Clinical Trials

6 Total Publications

MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer.
MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer.
Journal: Radiology
Published: September 03, 2024
View All 6 Publications
Similar Doctors
Advanced in Peritonitis
Dr. David S. Wang
Interventional Radiology | Radiology
Advanced in Peritonitis
Dr. David S. Wang
Interventional Radiology | Radiology

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
 (34.0 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Wang is an Interventional Radiologist and a Radiologist in Stanford, California. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Peritonitis. His top areas of expertise are Fibrolamellar Carcinoma, Alcoholic Cirrhosis, Ascites, Liver Embolization, and Gastrostomy.

Advanced in Peritonitis
Dr. Olufoladare G. Olorunsola
Interventional Radiology | Radiology
Advanced in Peritonitis
Dr. Olufoladare G. Olorunsola
Interventional Radiology | Radiology

California Advanced Imaging Medical Associates Inc

1101 Van Ness Ave, 
San Francisco, CA 
 (22.6 miles away)
415-600-3232
Experience:
17+ years
Languages Spoken:
English
See accepted insurances

Olufoladare Olorunsola is an Interventional Radiologist and a Radiologist in San Francisco, California. Dr. Olorunsola has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Peritonitis. His top areas of expertise are Ascites, Chronic Inflammatory Response Syndrome (CIRS), Fibrolamellar Carcinoma, Liver Embolization, and Gastrostomy.

Advanced in Peritonitis
Dr. Andrew Kesselman
Radiology
Advanced in Peritonitis
Dr. Andrew Kesselman
Radiology

Stanford Hospital And Clinics

965 High St, 
Palo Alto, CA 
 (33.3 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andrew Kesselman is a Radiologist in Palo Alto, California. Dr. Kesselman is rated as an Advanced provider by MediFind in the treatment of Peritonitis. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Urothelial Cancer, Thrombectomy, and Prostatic Artery Embolization.

VIEW MORE PERITONITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gandhi's expertise for a condition
ConditionClose
      • Advanced
      • Chronic Cough
        Dr. Gandhi is
        Advanced
        . Learn about Chronic Cough.
        See more Chronic Cough experts
      • Melorheostosis
        Dr. Gandhi is
        Advanced
        . Learn about Melorheostosis.
        See more Melorheostosis experts
      • Melorheostosis with Osteopoikilosis
        Dr. Gandhi is
        Advanced
        . Learn about Melorheostosis with Osteopoikilosis.
        See more Melorheostosis with Osteopoikilosis experts
      • Osteopenia
        Dr. Gandhi is
        Advanced
        . Learn about Osteopenia.
        See more Osteopenia experts
      • Premature Ovarian Failure
        Dr. Gandhi is
        Advanced
        . Learn about Premature Ovarian Failure.
        See more Premature Ovarian Failure experts
      • Experienced
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Gandhi is
        Experienced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Boils
        Dr. Gandhi is
        Experienced
        . Learn about Boils.
        See more Boils experts
      • Bronchiectasis
        Dr. Gandhi is
        Experienced
        . Learn about Bronchiectasis.
        See more Bronchiectasis experts
      • Carbuncle
        Dr. Gandhi is
        Experienced
        . Learn about Carbuncle.
        See more Carbuncle experts
      • Cerebral Arteriovenous Malformation
        Dr. Gandhi is
        Experienced
        . Learn about Cerebral Arteriovenous Malformation.
        See more Cerebral Arteriovenous Malformation experts
      • Cholesterol Pneumonia
        Dr. Gandhi is
        Experienced
        . Learn about Cholesterol Pneumonia.
        See more Cholesterol Pneumonia experts
      View All 43 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.